Hydramnios/ Oligohydramnios Flashcards
1
Q
Amniotic Fluid
A
- clear liquid that surrounds the fetus in the uterus
- clear, straw-colored substance
- odorless
- fetus’s urine makes up most of the amniotic fluid after about 20 weeks of pregnancy
- about 500ml enter and leave the amniotic sac per hour
○ Gradual increase up to 36 weeks to around 600-1000 ml then decrease after that
■ 500 ml – 18 weeks
■ 800 ml – 34 weeks
■ 600 ml – at term pregnancy up to 14 weeks
2
Q
Amniotic Fluid Purpose
A
- development of fetal lungs
- protect fetus from infection
- develop muscle and bones
- prevents umbilical cord from being compressed (for nutrients)
- helps digestive and respiratory system to develop
- regulate fetal body temperature
- protect fetus from mother’s movements (fall or sudden blow)
3
Q
Amniotic Fluid Purpose
A
- development of fetal lungs
- protect fetus from infection
- develop muscle and bones
- prevents umbilical cord from being compressed (for nutrients)
- helps digestive and respiratory system to develop
- regulate fetal body temperature
- protect fetus from mother’s movements (fall or sudden blow)
4
Q
Amniotic Fluid Clinical Importance
A
- screening for fetal malformation (serum alpha-fetoprotein)
- assessment of fetal well-being (amniotic fluid index; usually done during sonography/ ultrasound)
- assessment of fetal lung maturity (L/S ratio)
○ Lecithin Myelin
○ 2:0 to 2.5 - diagnosis and follow-up of labor
- diagnosis of PROM (ferning test)
○ Nitrazine paper test
○ Blue = prom
○ Yellow = urine
5
Q
Amniotic Fluid Volume Assessment
A
- fundal height measurement is unreliable
- objective assessment is done through ultrasonography
○ deepest vertical pool
○ amniotic fluid index (AFI) or single maximal vertical pocket (MVP)
OLIGOHYDRAMNIOS
POLYHYDRAMNIOS
6
Q
Polyhydramnios
A
- increased amniotic fluid volume relative to AOG
- excess fluid volume of 2000 mL and/ or AFI above 24 cm
7
Q
Polyhydramnios Complications
A
- fetal malpresentation: breech
- premature rupture of membranes (too wide, overstretch)
- preterm birth
- prolapsed cord (umbilical cord slips down first than the baby)
8
Q
Polyhydramnios Etiology
A
- fetal anomalies (20%)
- placental abnormalities
- maternal causes (30%)
9
Q
Polyhydramnios Etiology (Fetal Anomalies)
A
- anencephaly
- open spina bifida
- esophageal atresia
- hydrops fetalis (baby cannot manage fluid inside body)
10
Q
Polyhydramnios Etiology (Placental Abnormalities)
A
- chorioangioma (tumor grows in placenta, increased blood vessels that compresses umbilical vessel)
11
Q
Polyhydramnios Etiology (Maternal Causes)
A
- diabetes mellitus (increased risk for hyperglycemia, increases fetal sugar and fetal diuresis)
- pregnancy induced hypertension (edema formation due to placental implantation problems)
12
Q
Polyhydramnios Assessment
A
- discrepancy between fundal height and AOG
- rapid growth of uterus
- shortness of breath (diaphragm pressure)
- discomfort in abdomen
- lower extremity varicosities
- uterine contractions due to overstretching of uterus
- weight gain (2 lbs/ week = 2nd trimester; 1 lb/ week = 3rd trimester)
13
Q
Polyhydramnios Medical Management
A
- amniocentesis
- tocolytic therapy
14
Q
Amniocentesis
A
- prenatal diagnostic test
- small amount of amniotic fluid is removed to determine genetic abnormality
- artificial rupture of the membrane to reduce fluid and pressure
- transiently effective
- done daily to be effective
- watch out for risk for infection
15
Q
Tocolytic Therapy
A
prostaglandin synthesis inhibitor (Indomethacin) = noninvasive treatment = decrease amniotic fluid volume by decreasing fetal urinary output but may cause premature closure of the fetal ductus arteriosus